Skip to main content
Livermore
Livermore
ZHEN

Acrivon Therapeutics, Inc.

ACRV
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001781174

In the last 90 days, Acrivon Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 46 institutions reported holding it in 13F filings for Q2 2026, worth $38.1M in total; no superinvestor holds it.

13F holders, Q2 2024

Institutional positions in Acrivon Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
55
+7 vs. Q1 2024
Shares held
23.5M
+8.22M (+53.9%) vs. Q1 2024
Total value
$136.1M
+$27.1M (+24.9%) vs. Q1 2024
New holders
12
25 more added
Sold out
5
6 more reduced

Compare with Q1 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ACRV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2024: 55 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 18 institutionsQ1 2023: 39 institutionsQ2 2023: 40 institutionsQ3 2023: 43 institutionsQ4 2023: 42 institutionsQ1 2024: 48 institutionsQ2 2024: 55 institutionsQ3 2024: 55 institutionsQ4 2024: 63 institutionsQ1 2025: 63 institutionsQ2 2025: 53 institutionsQ3 2025: 48 institutionsQ4 2025: 48 institutionsQ1 2026: 44 institutionsQ2 2026: 46 institutions
Value heldQ2 2024: $136.1M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $170.4MQ1 2023: $191.1MQ2 2023: $196.0MQ3 2023: $144.3MQ4 2023: $74.5MQ1 2024: $109.0MQ2 2024: $136.1MQ3 2024: $160.8MQ4 2024: $140.0MQ1 2025: $45.7MQ2 2025: $21.2MQ3 2025: $31.7MQ4 2025: $44.9MQ1 2026: $22.6MQ2 2026: $38.1M
Institutions holding ACRV and their total value by quarter
QuarterHoldersValue
Q2 202646$38.1M
Q1 202644$22.6M
Q4 202548$44.9M
Q3 202548$31.7M
Q2 202553$21.2M
Q1 202563$45.7M
Q4 202463$140.0M
Q3 202455$160.8M
Q2 202455$136.1M
Q1 202448$109.0M
Q4 202342$74.5M
Q3 202343$144.3M
Q2 202340$196.0M
Q1 202339$191.1M
Q4 202218$170.4M
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2024

Shares, value and share of portfolio for each institution holding Acrivon Therapeutics, Inc.; share changes are against Q1 2024.

Institutions holding ACRV in Q2 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Ra Capital Management, L.P.8,340,508$48.4M0.64%+3,530,000+73.4%Added
Perceptive Advisors LLC5,360,858$31.1M0.75%+2,353,000+78.2%Added
Sands Capital Ventures, LLC2,122,605$12.3M4.12%+470,000+28.4%Added
Citadel Advisors LLC2,119,646$12.3M0.01%+439,619+26.2%Added
Marshall Wace, LLP948,866$5.50M0.01%+351,397+58.8%Added
Wellington Management Group LLP888,130$5.15M0.00%00.0%Unchanged
BlackRock Inc.767,020$4.45M0.00%+23,119+3.1%Added
Vanguard Group Inc745,510$4.32M0.00%+238,325+47.0%Added
Paradigm Biocapital Advisors LP659,724$3.83M0.15%+659,724New
Geode Capital Management, LLC308,393$1.79M0.00%+65,547+27.0%Added
State Street Corp178,663$1.04M0.00%+45,387+34.1%Added
Charles Schwab Investment Management Inc143,958$835.0K0.00%+66,576+86.0%Added
DAFNA Capital Management LLC121,351$703.8K0.17%−10,000−7.6%Reduced
Northern Trust Corp114,053$661.5K0.00%+6,303+5.8%Added
UBS Oconnor LLC105,249$610.4K0.02%−21,700−17.1%Reduced
Bridgeway Capital Management, LLC58,181$337.4K0.01%00.0%Unchanged
Renaissance Technologies LLC54,500$316.1K0.00%−48,100−46.9%Reduced
Baker Bros. Advisors LP52,885$306.7K0.00%00.0%Unchanged
Exchange Traded Concepts, LLC42,864$248.6K0.01%−13,336−23.7%Reduced
Bank of New York Mellon Corp36,632$212.5K0.00%+12,219+50.1%Added
Jane Street Group, LLC30,714$178.1K0.00%+30,714New
Bank of America Corp27,550$159.8K0.00%+21,511+356.2%Added
Goldman Sachs Group Inc24,384$141.4K0.00%+24,384New
Barclays PLC22,033$127.8K0.00%+709+3.3%Added
Morgan Stanley17,249$100.0K0.00%+60.0%Added
Squarepoint Ops LLC17,207$99.8K0.00%+17,207New
Rhumbline Advisers16,209$94.0K0.00%+5,320+48.9%Added
Marex Group plc13,187$76.5K0.00%+13,187New
Walleye Capital LLC12,721$73.8K0.00%+12,721New
Occudo Quantitative Strategies LP12,552$72.8K0.01%+12,552New
Nuveen Asset Management, LLC11,821$68.6K0.00%00.0%Unchanged
UBS Group AG11,152$64.7K0.00%−1,593−12.5%Reduced
AAFCPAs Wealth Management, LLC10,678$61.9K0.03%00.0%Unchanged
XTX Topco Ltd10,493$60.9K0.01%+10,493New
Dimensional Fund Advisors LP10,066$58.4K0.00%+10,066New
Mirae Asset Global ETFs Holdings Ltd.6,508$37.7K0.00%+6,508New
Corebridge Financial, Inc.6,355$36.9K0.00%+6,355New
JPMorgan Chase & Co5,243$30.4K0.00%+284+5.7%Added
Wells Fargo & Company5,191$30.1K0.00%+892+20.7%Added
Citigroup Inc5,082$29.5K0.00%+546+12.0%Added
Advisor Group Holdings, Inc.5,080$29.5K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)3,779$21.9K0.00%+2,962+362.5%Added
New York State Common Retirement Fund2,314$13.4K0.00%+41+1.8%Added
FMR LLC1,648$9.56K0.00%+621+60.5%Added
Russell Investments Group, Ltd.1,169$6.78K0.00%+946+424.2%Added
Royal Bank of Canada1,116$6.00K0.00%+838+301.4%Added
California State Teachers Retirement System856$4.96K0.00%−371−30.2%Reduced
Legal & General Group Plc839$4.87K0.00%00.0%Unchanged
STRS Ohio800$4.64K0.00%00.0%Unchanged
Ameritas Investment Partners, Inc.695$4.03K0.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec400$2.32K0.00%+400New
Amalgamated Bank378$2.00K0.00%00.0%Unchanged
Avion Wealth88$00.00%00.0%Unchanged
CWM, LLC23$00.00%+20+666.7%Added
Capital Advisors, Ltd. LLC48$00.00%00.0%Unchanged
Millennium Management LLC0$00.00%−95,497−100.0%Sold out
Prelude Capital Management, LLC0$00.00%−13,000−100.0%Sold out
Raymond James & Associates0$00.00%−10,200−100.0%Sold out
American International Group, Inc.0$00.00%−6,016−100.0%Sold out
Catalyst Funds Management Pty Ltd0$00.00%−1,044−100.0%Sold out